<DOC>
	<DOCNO>NCT03043014</DOCNO>
	<brief_summary>Surgical abortion one frequently surgery woman world . 43 million annually perform world . 90 % abortion perform first trimester pregnancy 13 week . Legal surgical abortion first trim pregnancy low risk intervention mortality rate low 1/100 000 abortion , risk complication 0.3 % 3.4 % .</brief_summary>
	<brief_title>Cervical Preparation Abortions Under Paracervical Block First Trimester :</brief_title>
	<detailed_description>Surgical abortion one frequently surgery woman world . 43 million annually perform world . Legal surgical abortion first trim pregnancy low risk intervention mortality rate low 1/100 000 abortion , risk complication 0.3 % 3.4 % . In France , 75 % surgical abortion perform general anesthesia ( GA ) . Nevertheless , risk complication higher GA . The risk death important ( 0,58 100 000 ) GA. GA increase factor 1,7 risk bleeding , 2,2 risk uterine perforation , 8,2 risk intra-abdominal bleeding , 2,9 risk cervical tearing , 5 risk transfusion . The difficulty pain control local anesthetia ( LA ) explain method less choosen woman . Indeed , lot woman consider surgical abortion LA extremely uncomfortable . The paracervical block abortion LA first trimester demonstrate efficiency reduction per-operating pain whatever term pregnancy compare absence anesthesia . The cervical preparation demonstrate benefit term cervical dilation , per-operating bleeding , complication incidence . The misoprostol mifepristone 2 molecule recommend cervical preparation first trimester</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>age 18 single intra uterine pregnancy whose term 6 14 week day abortion estimate ultrasound measurement craniocaudal length 5 84 millimeter surgical abortion local anesthesia inform write consent minor multiple pregnancy Uterine malformation coagulation disorder define biological parameter ( TP &lt; 70 % , TCA patient / control ratio &lt; 1.20 ) Allergy hypersensitivity active substance excipients Contraindication mifepristone chronic renal insufficiency severe asthma uncontrolled treatment hereditary porphyria allergy active substance excipients ; affiliate social security system ; inform consent . Suspicion ectopic pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>